Roxas, Jandrea Mae V.
HRN: 20-77-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/08/2023
07/15/2023
IVT
375mg
Q6
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes